123 related articles for article (PubMed ID: 7535617)
1. Helicobacter pylori aggregating activity of gastric mucin with ulcer healing by ebrotidine.
Piotrowski J; Majka J; Piotrowski E; Murty VL; Gabryelewicz A; Slomiany A; Slomiany BL
Biochem Mol Biol Int; 1994 Nov; 34(5):875-81. PubMed ID: 7535617
[TBL] [Abstract][Full Text] [Related]
2. Anti-Helicobacter pylori activities of ebrotidine. A review of biochemical and animal experimental studies and data.
Slomiany BL; Piotrowski J; Slomiany A
Arzneimittelforschung; 1997 Apr; 47(4A):475-82. PubMed ID: 9205747
[TBL] [Abstract][Full Text] [Related]
3. Enhancement in the protective qualities of gastric mucus by ebrotidine during duodenal ulcer healing.
Slomiany BL; Piotrowski J; Majka J; Czajkowski A; Slomiany A; Gabryelewicz A
Gen Pharmacol; 1995 Sep; 26(5):1039-44. PubMed ID: 7557247
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of Helicobacter pylori urease activity by ebrotidine.
Piotrowski J; Slomiany A; Slomiany BL
Biochem Mol Biol Int; 1995 Oct; 37(2):247-53. PubMed ID: 8673007
[TBL] [Abstract][Full Text] [Related]
5. Effect of ebrotidine on gastric mucosal inflammatory responses to Helicobacter pylori lipopolysaccharide.
Slomiany BL; Piotrowski J; Slomiany A
J Physiol Pharmacol; 1999 Sep; 50(3):391-404. PubMed ID: 10574469
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of gastric mucosal mucin receptor by H. pylori lipopolysaccharide: effect of ebrotidine.
Slomiany BL; Piotrowski J; Murty VL; Slomiany A
Gen Pharmacol; 1995 Nov; 26(7):1553-8. PubMed ID: 8690245
[TBL] [Abstract][Full Text] [Related]
7. Gastroprotective properties of ebrotidine. A review.
Slomiany BL; Piotrowski J; Slomiany A
Arzneimittelforschung; 1997 Apr; 47(4A):459-67. PubMed ID: 9205744
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and secretion of gastric sulfomucin in the presence of ebrotidine, a new antiulcer agent.
Slomiany BL; Lopez RA; Slomiany A
Biochem Int; 1992 Dec; 28(4):665-74. PubMed ID: 1482403
[TBL] [Abstract][Full Text] [Related]
9. Enhancement in the protective qualities of gastric mucus with combination therapy of ebrotidine and amoxicillin for H. pylori eradication.
Slomiany BL; Piotrowski J; Slomiany A; Konturek JW; Domschke WW
Gen Pharmacol; 1998 Aug; 31(2):227-31. PubMed ID: 9688464
[TBL] [Abstract][Full Text] [Related]
10. Susceptibility of Helicobacter pylori to antimicrobial agents: effect of ebrotidine and ranitidine.
Piotrowski J; Piotrowski E; Slomiany A; Slomiany BL
J Physiol Pharmacol; 1995 Dec; 46(4):463-9. PubMed ID: 8770790
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of Helicobacter pylori colonization by an antiulcer agent, sulglycotide.
Czajkowski A; Piotrowski J; Yotsumoto F; Slomiany A; Slomiany BL
Biochem Mol Biol Int; 1993 Apr; 29(5):965-71. PubMed ID: 8508147
[TBL] [Abstract][Full Text] [Related]
12. Ebrotidine--a nostrum for ulcer.
Grover JK; Rathi SS; Vats V
Trop Gastroenterol; 1997; 18(3):111-3. PubMed ID: 9385853
[No Abstract] [Full Text] [Related]
13. Gastric mucosal EGF and PDGF receptor expression with ulcer healing by ebrotidine.
Slomiany BL; Piotrowski J; Czajkowski A; Yotsumoto F; Slomiany A
Am J Gastroenterol; 1994 Jun; 89(6):894-7. PubMed ID: 8198101
[TBL] [Abstract][Full Text] [Related]
14. Effect of ebrotidine on the synthesis and secretion of gastric sulfomucin.
Slomiany BL; Lopez RA; Liau YH; Slomiany A
Gen Pharmacol; 1993 May; 24(3):611-7. PubMed ID: 8365641
[TBL] [Abstract][Full Text] [Related]
15. Sucralfate counteracts the inhibition of gastric mucosal mucin receptor by Helicobacter pylori lipopolysaccharide.
Slomiany A; Piotrowski J; Slomiany BL
Scand J Gastroenterol Suppl; 1995; 210():77-81. PubMed ID: 8578214
[TBL] [Abstract][Full Text] [Related]
16. Ebrotidine.
Patel SS; Wilde MI
Drugs; 1996 Jun; 51(6):974-80; discussion 981. PubMed ID: 8736619
[TBL] [Abstract][Full Text] [Related]
17. Ebrotidine effect on the proteolytic and lipolytic activities of Helicobacter pylori.
Slomiany BL; Piotrowski J; Mojtahed H; Slomiany A
Gen Pharmacol; 1992 Mar; 23(2):203-6. PubMed ID: 1639232
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of gastric mucosal laminin receptor by Helicobacter pylori lipopolysaccharide: effect of ebrotidine.
Piotrowski J; Morita M; Slomiany A; Slomiany BL
Biochem Int; 1992 Jun; 27(1):131-8. PubMed ID: 1385705
[TBL] [Abstract][Full Text] [Related]
19. Effects of Helicobacter pylori Infection on gastric mucin expression.
Kang HM; Kim N; Park YS; Hwang JH; Kim JW; Jeong SH; Lee DH; Lee HS; Jung HC; Song IS
J Clin Gastroenterol; 2008 Jan; 42(1):29-35. PubMed ID: 18097286
[TBL] [Abstract][Full Text] [Related]
20. Regulation of gastric mucosal calcium channel activity by an antiulcer agent, ebrotidine.
Slomiany BL; Liu J; Piotrowski J; Czajkowski A; Yotsumoto F; Slomiany A
J Physiol Pharmacol; 1994 Mar; 45(1):121-31. PubMed ID: 7519082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]